Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review

Detalhes bibliográficos
Autor(a) principal: Nolasco, Izis Moara Morais Leão
Data de Publicação: 2020
Outros Autores: Resende, Juliana Resende
Tipo de documento: Artigo
Idioma: por
Título da fonte: Scire Salutis
Texto Completo: https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2020.002.0005
Resumo: Skin care is something more and more frequent nowadays, with hyperpigmentation being among the first complaints of patients in aesthetic procedures. Mandelic acid is an alpha-hydroxy-acid widely used in the treatment of hyperchromias due to its effective lightening action that can be used in all phototypes safely. Because it contains a high-weight molecule, the active agent slowly permeates the skin acting on the synthesis of melanin. The present study aims to briefly explain the structure of the epidermis and melanocyte, the synthesis of melanin as responsible for skin pigmentation and the action of mandelic peeling as a depigmenting active. The methodology used was the bibliographic study that consists of collecting information based on studies pre-existing information available in books, articles and websites related to health. After the selection of the study material, the reading, thorough analysis and interpretation of the information was carried out, providing support for the data file and consequent theoretical foundation. From the analysis of the information, it can be concluded that hyperchromias are the result of several factors and that mandelic acid is a less aggressive option for the treatment of this dysfunction, presenting satisfactory results. Since it is a molecule with high weight, its permeation is slower and more uniform, acting as a collagen stimulator, however, its indiscriminate use can cause burns, bruises and other adverse effects, making its administration by trained personnel advisable.
id ESS-1_598541d166de5700feae9cf2c2d56f43
oai_identifier_str oai:ojs.pkp.sfu.ca:article/3933
network_acronym_str ESS-1
network_name_str Scire Salutis
repository_id_str
spelling Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature reviewUso do ácido mandélico no tratamento de hipercromias pós-inflamatória: uma revisão de literaturaEpidermeHipercromiasMelanogeneseÁcido MandélicoEpidermisHyperchromiasMelanogenesisMandelic AcidSkin care is something more and more frequent nowadays, with hyperpigmentation being among the first complaints of patients in aesthetic procedures. Mandelic acid is an alpha-hydroxy-acid widely used in the treatment of hyperchromias due to its effective lightening action that can be used in all phototypes safely. Because it contains a high-weight molecule, the active agent slowly permeates the skin acting on the synthesis of melanin. The present study aims to briefly explain the structure of the epidermis and melanocyte, the synthesis of melanin as responsible for skin pigmentation and the action of mandelic peeling as a depigmenting active. The methodology used was the bibliographic study that consists of collecting information based on studies pre-existing information available in books, articles and websites related to health. After the selection of the study material, the reading, thorough analysis and interpretation of the information was carried out, providing support for the data file and consequent theoretical foundation. From the analysis of the information, it can be concluded that hyperchromias are the result of several factors and that mandelic acid is a less aggressive option for the treatment of this dysfunction, presenting satisfactory results. Since it is a molecule with high weight, its permeation is slower and more uniform, acting as a collagen stimulator, however, its indiscriminate use can cause burns, bruises and other adverse effects, making its administration by trained personnel advisable.O cuidado com a pele é algo cada vez mais frequente nos dias atuais, estando a hiperpigmentação entre as primeiras queixas dos pacientes em procedimentos estéticos. O ácido mandélico é um alfa-hidroxi-ácido amplamente utilizado no tratamento de hipercromias por sua eficaz ação clareadora que pode ser utilizada em todos os fototipos de forma segura. Por conter uma molécula de alto peso, o ativo permeia de forma lenta na pele agindo na síntese de melanina. O presente estudo visa explicar resumidamente a estrutura da epiderme e do melanócito, a síntese da melanina como responsável pela pigmentação cutânea e a ação do peeling mandélico como ativo despigmentante A metodologia utilizada foi o estudo bibliográfico que consiste na coleta de informações baseando-se em estudos pré-existentes disponíveis em livros, artigos e sites inerentes à área da saúde. Após a seleção do material de estudo, foi realizado a leitura, análise minuciosa e interpretação das informações, dando subsídio para o fichamento de dados e consequente fundamentação teórica.  A partir da análise das informações pode-se concluir que as hipercromias são resultantes de diversos fatores e que o ácido mandélico é uma opção menos agressiva para o tratamento dessa disfunção, apresentando resultados satisfatórios. Por se tratar de uma molécula com alto peso, sua permeação é mais lenta e uniforme, agindo como um estimulador de colágeno, no entanto, seu uso indiscriminado pode acarretar queimaduras, equimoses e outros efeitos adversos, tornando aconselhável sua administração por pessoal capacitado.Sustenere Publishing2020-04-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2020.002.000510.6008/CBPC2236-9600.2020.002.0005Scire Salutis; Vol. 10 No. 2 (2020): Scire Salutis - Fev, Mar, Abr, Mai 2020; 35-42Scire Salutis; Vol. 10 Núm. 2 (2020): Scire Salutis - Fev, Mar, Abr, Mai 2020; 35-42Scire Salutis; v. 10 n. 2 (2020): Scire Salutis - Fev, Mar, Abr, Mai 2020; 35-422236-9600reponame:Scire Salutisinstname:Companhia Brasileira de Produção Científica (CBPC)instacron:ESSporhttps://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2020.002.0005/2049Copyright (c) 2020 Scire Salutisinfo:eu-repo/semantics/openAccessNolasco, Izis Moara Morais LeãoResende, Juliana Resende2020-07-14T13:34:48Zoai:ojs.pkp.sfu.ca:article/3933Revistahttps://sustenere.co/index.php/sciresalutisONGhttps://sustenere.co/index.php/sciresalutis/oai||carlos@arvore.org.br2236-96002236-9600opendoar:2020-07-14T13:34:48Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)false
dc.title.none.fl_str_mv Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
Uso do ácido mandélico no tratamento de hipercromias pós-inflamatória: uma revisão de literatura
title Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
spellingShingle Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
Nolasco, Izis Moara Morais Leão
Epiderme
Hipercromias
Melanogenese
Ácido Mandélico
Epidermis
Hyperchromias
Melanogenesis
Mandelic Acid
title_short Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
title_full Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
title_fullStr Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
title_full_unstemmed Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
title_sort Use of mandelic acid in the treatment of post-inflammatory hyperchromias: a literature review
author Nolasco, Izis Moara Morais Leão
author_facet Nolasco, Izis Moara Morais Leão
Resende, Juliana Resende
author_role author
author2 Resende, Juliana Resende
author2_role author
dc.contributor.author.fl_str_mv Nolasco, Izis Moara Morais Leão
Resende, Juliana Resende
dc.subject.por.fl_str_mv Epiderme
Hipercromias
Melanogenese
Ácido Mandélico
Epidermis
Hyperchromias
Melanogenesis
Mandelic Acid
topic Epiderme
Hipercromias
Melanogenese
Ácido Mandélico
Epidermis
Hyperchromias
Melanogenesis
Mandelic Acid
description Skin care is something more and more frequent nowadays, with hyperpigmentation being among the first complaints of patients in aesthetic procedures. Mandelic acid is an alpha-hydroxy-acid widely used in the treatment of hyperchromias due to its effective lightening action that can be used in all phototypes safely. Because it contains a high-weight molecule, the active agent slowly permeates the skin acting on the synthesis of melanin. The present study aims to briefly explain the structure of the epidermis and melanocyte, the synthesis of melanin as responsible for skin pigmentation and the action of mandelic peeling as a depigmenting active. The methodology used was the bibliographic study that consists of collecting information based on studies pre-existing information available in books, articles and websites related to health. After the selection of the study material, the reading, thorough analysis and interpretation of the information was carried out, providing support for the data file and consequent theoretical foundation. From the analysis of the information, it can be concluded that hyperchromias are the result of several factors and that mandelic acid is a less aggressive option for the treatment of this dysfunction, presenting satisfactory results. Since it is a molecule with high weight, its permeation is slower and more uniform, acting as a collagen stimulator, however, its indiscriminate use can cause burns, bruises and other adverse effects, making its administration by trained personnel advisable.
publishDate 2020
dc.date.none.fl_str_mv 2020-04-10
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2020.002.0005
10.6008/CBPC2236-9600.2020.002.0005
url https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2020.002.0005
identifier_str_mv 10.6008/CBPC2236-9600.2020.002.0005
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2020.002.0005/2049
dc.rights.driver.fl_str_mv Copyright (c) 2020 Scire Salutis
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Scire Salutis
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sustenere Publishing
publisher.none.fl_str_mv Sustenere Publishing
dc.source.none.fl_str_mv Scire Salutis; Vol. 10 No. 2 (2020): Scire Salutis - Fev, Mar, Abr, Mai 2020; 35-42
Scire Salutis; Vol. 10 Núm. 2 (2020): Scire Salutis - Fev, Mar, Abr, Mai 2020; 35-42
Scire Salutis; v. 10 n. 2 (2020): Scire Salutis - Fev, Mar, Abr, Mai 2020; 35-42
2236-9600
reponame:Scire Salutis
instname:Companhia Brasileira de Produção Científica (CBPC)
instacron:ESS
instname_str Companhia Brasileira de Produção Científica (CBPC)
instacron_str ESS
institution ESS
reponame_str Scire Salutis
collection Scire Salutis
repository.name.fl_str_mv Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)
repository.mail.fl_str_mv ||carlos@arvore.org.br
_version_ 1793890277832785920

Registros relacionados